Log in to save to my catalogue

Therapeutic strategy aiming at R0 resection for borderline-resectable esophageal squamous cell carci...

Therapeutic strategy aiming at R0 resection for borderline-resectable esophageal squamous cell carci...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2801982681

Therapeutic strategy aiming at R0 resection for borderline-resectable esophageal squamous cell carcinoma using induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil

About this item

Full title

Therapeutic strategy aiming at R0 resection for borderline-resectable esophageal squamous cell carcinoma using induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil

Publisher

Singapore: Springer Nature Singapore

Journal title

General thoracic and cardiovascular surgery, 2023-10, Vol.71 (10), p.584-590

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

Objective
Treatment for borderline resectable (cT3br) esophageal squamous cell carcinoma (SCC) is currently undefined. This study aimed to analyze the outcome of treatment strategies including induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) against T3br esophageal SCC.
Methods
A total of 32 patients with cT3br es...

Alternative Titles

Full title

Therapeutic strategy aiming at R0 resection for borderline-resectable esophageal squamous cell carcinoma using induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2801982681

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2801982681

Other Identifiers

ISSN

1863-6705

E-ISSN

1863-6713

DOI

10.1007/s11748-023-01934-7

How to access this item